Tower Research Capital LLC (Trc) Liminal Bio Sciences Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.92 $20,949 - $38,196	-9,744 Reduced 96.06%	400 $1,000
Q2 2021 Aug 16, 2021	BUY	$3.75 - $5.17 $36,540 - $50,376	9,744 Added 2436.0%	10,144 $40,000
Q3 2020 Nov 16, 2020	SELL	$10.51 - $23.79 $3,153 - $7,137	-300 Reduced 42.86%	400 $4,000
Q2 2020 Aug 13, 2020	SELL	$6.3 - $11.35 $1,890 - $3,405	-300 Reduced 30.0%	700 $7,000
Q1 2020 May 15, 2020	BUY	$5.4 - $12.93 $2,160 - $5,172	400 Added 66.67%	1,000 $6,000
Q4 2019 Feb 07, 2020	BUY	$5.47 - $11.33 $3,282 - $6,798	600 New	600 $5,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.